Synthesis and Anti-Cancer Activity In Vitro of Synephrine Derivatives
Synthesis and Anti-Cancer Activity In Vitro of Synephrine Derivatives
About this item
Full title
Author / Creator
Publisher
Switzerland: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Switzerland: MDPI AG
Subjects
More information
Scope and Contents
Contents
Glucocorticoids (GCs) are routinely used to treat hematological malignancies; however, long-term treatment with GCs can lead to atrophic and metabolic adverse effects. Selective glucocorticoid receptor agonists (SEGRAs) with reduced side effects may act as a superior alternative to GCs. More than 30 SEGRAs have been described so far, yet none of th...
Alternative Titles
Full title
Synthesis and Anti-Cancer Activity In Vitro of Synephrine Derivatives
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_afe55d0166ed4260afa692830aed7644
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_afe55d0166ed4260afa692830aed7644
Other Identifiers
ISSN
2218-273X
E-ISSN
2218-273X
DOI
10.3390/biom15010002
